Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal
Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
medline:
21
1
2024
pubmed:
21
1
2024
entrez:
20
1
2024
Statut:
ppublish
Résumé
The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment, assessment of response to treatment, and follow-up of both newly diagnosed and previously treated WM/LPL.
Identifiants
pubmed: 38244272
doi: 10.6004/jnccn.2024.0001
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM